Clinical trial
Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary…
NCT00457015 · Shire, Industry · Completed
Key facts
| NCT number | NCT00457015 |
|---|---|
| Title | Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE) |
| Official title | EDEMA4: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of DX-88 (Ecallantide) for the Treatment of Acute Attacks of Hereditary Angioedema |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hereditary Angioedema (HAE) |
| Intervention type | Drug |
| Interventions | ecallantide, Phosphate Buffer Saline (PBS), pH 7.0 |
| Enrollment | 96 |
| Start date | Apr 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Apr 5, 2007 |
| Last update posted | Jun 8, 2021 |
| Countries | Canada, Jordan, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: